EyePoint Completes Enrollment in Phase 3 Diabetic Macular Edema Trials

Phase 3Positive

AI Analysis

Summary

EyePoint has completed enrollment in its Phase 3 clinical trials for a diabetic macular edema treatment. The completion of enrollment represents a key milestone ahead of upcoming efficacy data readout.

Clinical Trial Data

Phase

Phase 3

Outcome Details

Enrollment completed

Importance:6/10

Sentiment:

0.50

Phase 3Diabetic Macular EdemaClinical TrialEnrollment

Related Companies

$EYPT

Read the original article

Published by yahoo_finance on July 30, 2026 2:15 PM

Read Original